{
    "organizations": [],
    "uuid": "14c8d277ddc7911ee65e7927d14b637169f61ead",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-richter-q4-net-profit-misses-esmya/brief-richter-q4-net-profit-misses-esmya-sales-beat-forecast-idUSL8N1Q10Y6",
    "ord_in_thread": 0,
    "title": "BRIEF-Richter Q4 net profit misses, Esmya sales beat forecast",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt :\n* Q4 NET PROFIT HUF 6.6 BILLION ($25.91 MILLION) VERSUS HUF 9.9 BILLION ANALYST FORECAST IN PORTFOLIO.HU SURVEY\n* Q4 REVENUES HUF 110.2 BILLION VERSUS HUF 108.8 BILLION ANALYST FORECAST\n* FULL-YEAR REVENUES RISE BY 14.8 PCT Y/Y TO EUR 1.44 BLN * FULL-YEAR 2017 OPERATING PROFIT MARGIN 15.5 PERCENT VERSUS 15-16 PERCENT GUIDANCE\n* FULL-YEAR REVENUES FROM UTERINE FIBROID MEDICINE ESMYA EUR 93 MILLION VERSUS EUR 85 MILLION GUIDANCE\n* EUROPEAN MEDICINES AGENCY IMPOSED TEMPORARY RESTRICTIONS ON ESMYA MEDICINE PENDING A CONCLUSION OF ITS REVIEW INTO RISKS\n* RICHTER HAS SAID RESTRICTIONS ON ESMYA WOULD LEAD TO TEMPORARY LOSS OF REVENUE FROM MEDICINE UNTIL EXPECTED FINAL RULING IN MAY\n* RICHTER SHARES FELL 6.6 PCT TO WEAKEST LEVEL SINCE DEC 2016 ON FRIDAY Further company coverage:\n$1 = 254.68 forints Reporting by Gergely Szakacs; Editing by Daniel Wallis\n ",
    "published": "2018-02-12T07:20:00.000+02:00",
    "crawled": "2018-02-13T04:41:52.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "richter",
        "gedeon",
        "vegyeszeti",
        "gyar",
        "nyrt",
        "q4",
        "net",
        "profit",
        "huf",
        "billion",
        "million",
        "versus",
        "huf",
        "billion",
        "analyst",
        "forecast",
        "survey",
        "q4",
        "revenue",
        "huf",
        "billion",
        "versus",
        "huf",
        "billion",
        "analyst",
        "forecast",
        "revenue",
        "rise",
        "pct",
        "eur",
        "bln",
        "operating",
        "profit",
        "margin",
        "percent",
        "versus",
        "percent",
        "guidance",
        "revenue",
        "uterine",
        "fibroid",
        "medicine",
        "esmya",
        "eur",
        "million",
        "versus",
        "eur",
        "million",
        "guidance",
        "european",
        "medicine",
        "agency",
        "imposed",
        "temporary",
        "restriction",
        "esmya",
        "medicine",
        "pending",
        "conclusion",
        "review",
        "risk",
        "richter",
        "said",
        "restriction",
        "esmya",
        "would",
        "lead",
        "temporary",
        "loss",
        "revenue",
        "medicine",
        "expected",
        "final",
        "ruling",
        "may",
        "richter",
        "share",
        "fell",
        "pct",
        "weakest",
        "level",
        "since",
        "dec",
        "friday",
        "company",
        "coverage",
        "forint",
        "reporting",
        "gergely",
        "szakacs",
        "editing",
        "daniel",
        "wallis"
    ]
}